Literature DB >> 8702465

Dynamin and beta-arrestin reveal distinct mechanisms for G protein-coupled receptor internalization.

J Zhang1, S S Ferguson, L S Barak, L Ménard, M G Caron.   

Abstract

The process of agonist-promoted internalization (sequestration) of G protein-coupled receptors (GPCRs) is intimately linked to the regulation of GPCR responsiveness. Following agonist-mediated desensitization, sequestration of GPCR is presumably associated with the dephosphorylation and recycling of functional receptors. However, the exact mechanisms responsible for GPCR sequestration, even for the prototypic beta2-adrenergic receptor (beta2AR), have remained controversial. We demonstrate here that dynamin, a GTPase that regulates the formation and internalization of clathrin-coated vesicles, is essential for the agonist-promoted sequestration of the beta2AR, suggesting that the beta2AR internalizes via the clathrin-coated vesicle-mediated endocytic pathway. In contrast, internalization of the angiotensin II type 1A receptor (AT1AR), another typical GPCR, does not require dynamin. In addition, the AT1AR internalizes independent of the function of beta-arrestin, a critical component for beta2AR cellular trafficking, but additional AT1ARs are mobilized to the dynamin-dependent pathway upon overexpression of beta-arrestin. These findings demonstrate that GPCRs can utilize distinct endocytic pathways, distinguishable by dynamin and beta-arrestin, and that beta-arrestins function as adaptor proteins specifically targeting GPCRs for dynamin-dependent endocytosis via clathrin-coated vesicles.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8702465     DOI: 10.1074/jbc.271.31.18302

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  79 in total

Review 1.  Structural features of heterotrimeric G-protein-coupled receptors and their modulatory proteins.

Authors:  H LeVine
Journal:  Mol Neurobiol       Date:  1999-04       Impact factor: 5.590

2.  Multiple endocytic pathways of G protein-coupled receptors delineated by GIT1 sensitivity.

Authors:  A Claing; S J Perry; M Achiriloaie; J K Walker; J P Albanesi; R J Lefkowitz; R T Premont
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

3.  Recycling and resensitization of delta opioid receptors.

Authors:  N Trapaidze; I Gomes; M Bansinath; L A Devi
Journal:  DNA Cell Biol       Date:  2000-04       Impact factor: 3.311

4.  Mu-opioid agonist inhibition of kappa-opioid receptor-stimulated extracellular signal-regulated kinase phosphorylation is dynamin-dependent in C6 glioma cells.

Authors:  L M Bohn; M M Belcheva; C J Coscia
Journal:  J Neurochem       Date:  2000-02       Impact factor: 5.372

Review 5.  G-protein coupled receptor kinases as modulators of G-protein signalling.

Authors:  M Bünemann; M M Hosey
Journal:  J Physiol       Date:  1999-05-15       Impact factor: 5.182

Review 6.  Entry of ricin and Shiga toxin into cells: molecular mechanisms and medical perspectives.

Authors:  K Sandvig; B van Deurs
Journal:  EMBO J       Date:  2000-11-15       Impact factor: 11.598

7.  Desensitization, internalization, and signaling functions of beta-arrestins demonstrated by RNA interference.

Authors:  Seungkirl Ahn; Christopher D Nelson; Tiffany Runyan Garrison; William E Miller; Robert J Lefkowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-11       Impact factor: 11.205

8.  Persistent cAMP signaling by thyrotropin (TSH) receptors is not dependent on internalization.

Authors:  Susanne Neumann; Elizabeth Geras-Raaka; Bernice Marcus-Samuels; Marvin C Gershengorn
Journal:  FASEB J       Date:  2010-06-10       Impact factor: 5.191

9.  Follicle-stimulating hormone (FSH) induced internalization of porcine FSH receptor in cultured porcine granulosa cells and Chinese hamster ovary cells transfected with recombinant porcine FSH receptor cDNA.

Authors:  C Zhu; H Tian; Z Xiong; H Xia
Journal:  J Tongji Med Univ       Date:  2001

10.  Homologous regulation of the alpha2C-adrenoceptor subtype in human hepatocarcinoma, HepG2.

Authors:  C Cayla; S Schaak; C Roquelaine; C Gales; F Quinchon; H Paris
Journal:  Br J Pharmacol       Date:  1999-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.